在两个严重喘诊所的本拉利祖马布和梅波利祖马布治疗结果
David Langton1,2, John Politis3, Taya Collyer2
1Department of Thoracic Medicine, Peninsula Health, Melbourne, Victoria, Australia.
Respirology (Carlton, Vic.)
|August 28, 2023
概括
贝纳利祖马布在严重的乙酸性喘患者中表现出比梅波利祖马布更高的疗效,显著减少了恶化并改善了肺功能 (FEV1). 这两种生物药物都改善了喘控制,但本拉利祖马布显示出更大程度的降低了血中乙氨基酸细胞.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘管理带来了挑战,特别是在eosinophilic表型.
- 针对特定炎症途径的生物疗法提供了新的治疗途径.
- 梅波利祖马布和本拉利祖马布是向IL-5或其受体的单克隆抗体.
研究的目的:
- 为了比较mepolizumab和benralizumab在严重喘患者的临床有效性.
- 为了评估两种治疗方法之间的恶化率,肺功能和血中乙氨基酸细胞计数的差异.
- 在现实世界第三级护理环境中评估治疗结果.
主要方法:
- 对204名严重喘患者进行前性观察研究 (117名梅波利祖马布,87名本拉利祖马布).
- 在基线,6个月和12个月收集的数据.
- 喘控制问卷 (ACQ) 的比较,恶化,FEV1和血液中异氨基酸细胞计数.
主要成果:
- 梅波利祖马布和本拉利祖马布都显著改善了ACQ,减少了恶化,并增加了FEV1.
- 与梅波利祖马布相比,本拉利祖马布在FEV1 (0.18L) 和恶化减少 (64%在12个月) 中的改善显著更大.
- 贝纳利祖马布在血液中实现了显著更大程度的降低乙氨基细胞计数 (-260 细胞/μL).
结论:
- 梅波利祖马布和本拉利祖马布都有效治疗严重的酸性喘.
- 本拉利祖马布在减少恶化和改善FEV1.1方面表现出卓越的疗效.
- 贝纳利祖马布也对血液中异氨基的减少产生了更明显的作用.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
298
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
298
01:19Antiasthma Drugs: Leukotriene Modifiers
353
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
353
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Asthma: Pathogenesis and Management
442
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
442
01:17Drugs Used in Lower Respiratory Disorders: Overview
487
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
487